ArticleScientific reports2024

Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition.

Sally A Fahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.